✦ LIBER ✦

Aborted myocardial infarction after primary percutaneous coronary intervention: Magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Scribed by Patel, Manesh R.; Westerhout, Cynthia M.; Granger, Christopher B.; Brener, Sorin J.; Fu, Yuling; Siha, Hany; Kim, Raymond J.; Armstrong, Paul W.

Book ID: 121780292
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 335 KB
Volume: 165
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2012.10.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ST-Segment Recovery and Outcome After Pr

ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

✍ Buller, C. E.; Fu, Y.; Mahaffey, K. W.; Todaro, T. G.; Adams, P.; Westerhout, C. 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 559 KB

Pexelizumab and Infarct Size in Patients

Pexelizumab and Infarct Size in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Delayed Enhancement Cardiac Magnetic Resonance Substudy From the APEX-AMI Trial

✍ Manesh R. Patel; Stephen G. Worthley; Amanda Stebbins; Thorsten Dill; Frank E. R 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 602 KB

Pexelizumab fails to inhibit assembly of

Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

✍ Catherine Martel; Christopher B. Granger; Marta Ghitescu; Amanda Stebbins; Annik 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 594 KB

Pexelizumab fails to inhibit assembly of

✍ Gen-Min Lin; Yi-Hwei Li; Lamin E.S. Jaiteh; Chih-Lu Han 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Assessment of Pexelizumab in Acute Myoca

Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention

✍ Paul W. Armstrong; Peter X. Adams; Hussein R. Al-Khalidi; Christian Hamm; David 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Does silent myocardial infarction add pr

Does silent myocardial infarction add prognostic value in ST-elevation myocardial infarction patients without a history of prior myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial

✍ Mustafa Toma; Yuling Fu; Justin A. Ezekowitz; Finlay A. McAlister; Cynthia M. We 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 337 KB